Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.
about
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challengesCXCR2: a target for pancreatic cancer treatment?Exploiting inflammation for therapeutic gain in pancreatic cancerSolution Structure of CXCL5 — A Novel Chemokine and Adipokine Implicated in Inflammation and ObesityImmune checkpoint and inflammation as therapeutic targets in pancreatic carcinomaMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer.CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.The role of chemoattractant receptors in shaping the tumor microenvironment.The emerging role of CXC chemokines and their receptors in cancer.Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight.A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predicts risk of disease progression and survival of nasopharyngeal carcinoma patients.Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies.Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesionsCXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune responseCXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growthCurcumin suppresses NTHi-induced CXCL5 expression via inhibition of positive IKKβ pathway and up-regulation of negative MKP-1 pathway.Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.Chemokines, chemokine receptors and the gastrointestinal system.The immune network in pancreatic cancer development and progression.Molecular Basis of Chemokine CXCL5-Glycosaminoglycan InteractionsCXCL5 stimulation of RANK ligand expression in Paget's disease of bone.Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcomaRole of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.Lymph node metastasis and the physicochemical micro-environment of pancreatic ductal adenocarcinoma xenografts.CXCR2-Dependent Accumulation of Tumor-Associated Neutrophils Regulates T-cell Immunity in Pancreatic Ductal Adenocarcinoma.Insulin Receptor and GPCR Crosstalk Stimulates YAP via PI3K and PKD in Pancreatic Cancer Cells.KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.The clinical significance of CXCL5 in non-small cell lung cancer.Human papillomavirus oncogenes reprogram the cervical cancer microenvironment independently of and synergistically with estrogen.Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma.Melanoma exosomes promote mixed M1 and M2 macrophage polarization.CXCL5 secreted from adipose tissue-derived stem cells promotes cancer cell proliferation.
P2860
Q26866236-037CD28C-E8B5-4640-8334-AA95699C28D1Q27021588-CA6858FC-5015-45C6-A686-50A1CA0EBDA6Q27027661-F7ABA722-37BC-4AA6-A85D-31E70E68EDCDQ27682811-293CE8F2-F9DE-4CAF-A7B3-608CF6CC5E4AQ28069864-7664CC03-5C5E-4FEC-8FD0-470E2462AEBFQ30278005-1BF67E47-346F-4376-93E4-1BC202F5B7AEQ30358993-1D7F4CCD-A10E-4E85-80BE-680D7EBDC39CQ33562564-F8A9FDDD-0953-4988-B066-4F2CD457DE08Q33993124-AA11A0E3-D809-4696-AB54-81219510F9E9Q34263645-9022BBA8-FA62-4306-AEC1-2E9F92B484DBQ34294091-7016819F-B823-4236-9427-21665CAC6E34Q34612497-A20E2725-5B1C-49F4-995B-55420B3A730EQ35498810-EB5D3E63-AC70-42A3-AFAC-AA4C6CE429ECQ35934127-6B3AC561-8A98-42EF-B7B7-62E93FF9B3C8Q35973308-ABEA0B15-658C-4C6E-B322-06D5F41A7CA9Q35983671-8CDBB849-7676-4CCE-A9C7-4EF385FABC7AQ36029913-9FD4E763-C991-4B2C-9661-CC0109CD9353Q36041701-2BFBD766-84F4-4DA0-A9EE-BA87CABC55C3Q36284948-9C6DAFB1-E1F3-4740-977C-AF03AAE1018EQ36343870-3B974523-F381-4FEF-9BC1-1C980C6268BFQ36723785-A118173D-D997-42A7-9EF0-FF9FB05D2E88Q37188938-B20C1440-32DB-489B-AF8A-2969A6612656Q37416749-D83A8996-B0A3-4AAE-AFED-C43E64438D09Q38109160-FAB98C00-120F-4798-84A0-37B6E81EBB42Q38121412-42C8E0F3-086A-4458-B994-CDBCBB78AC2DQ38291506-E6CEBC3A-1DB5-4649-B701-49AC0398AF3DQ39188901-42C9D761-048C-48B3-BE33-974FC4B5D970Q39246205-F7BC2A0F-AE8C-4BC0-AA14-99DE86A5C49EQ39321350-F8A39D5A-7C88-4313-BE20-ACC2687EDBC7Q39396200-68EDF67C-A81B-4A92-837E-2F329495B1D1Q40936667-5A4AF569-486D-4523-AC54-DE3A3D85A91CQ41471434-17A6F324-F3C3-46E0-9DE2-67AA9F44503EQ42697314-4EB01AD7-BE78-492D-BC37-5001A52D667EQ46302561-FA8FE27E-FACD-402B-B150-0F4DFA0C2E3EQ46471150-DE8FAEE8-FF33-437D-A666-29E52A19C1AAQ47101861-2CCA4279-96EE-4E71-B4E8-B3AA87E08681Q47407749-FB45460A-90D5-42C6-8FF8-11571CCB7D67Q48583884-B67CA5EB-3215-474A-AAF6-22EFF7CD3F58Q49833213-D54F16F4-BBB8-40AF-82ED-44F1A0B7A682Q50040819-34A4243B-49DE-40EE-8193-B422F0412143
P2860
Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.
@ast
Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.
@en
type
label
Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.
@ast
Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.
@en
prefLabel
Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.
@ast
Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.
@en
P2093
P2860
P1476
Overexpression of CXCL5 is ass ...... tients with pancreatic cancer.
@en
P2093
David W Dawson
Guido Eibl
Howard A Reber
Jeffrey Kaplan
Jonathan King
Marie Burdick
Mark D Sugi
P2860
P304
P356
10.1016/J.AJPATH.2010.11.058
P407
P577
2011-03-01T00:00:00Z